Search Results

Found 1164 results for ""

ACRCSP Poster-Should-I-Be-Screened-for-Colorectal-Cancer June 2015

attachment

Should I be screened for colorectal cancer? All men and women 50 to 74 should be screened for colorectal cancer regularly. Talk to your healthcare provider about what screening test may be right for you. For more information on colorectal screening: 1-866-727-3926 | www.screeningforlife.ca The Alberta Colorectal Cancer Screening Program…

coloshouldi

attachment

ACRCSP Program and Practice Standards and Guidelines Jan 2014

attachment

January Alberta Colorectal Cancer Screening Program Standards and Guidelines Version 4.0 of 4.0 Part 1 Standards and Guidelines Draft Document Leaders Dr. Clarence Wong, Medical Lead ACRCSP, Gastroenterologist Dr. Huiming Yang, Medical Director, Healthy Living PPAH MaryAnne Zupancic, ACRCSP Implementation Specialist Note: The Standards and Guidelines Part 1 and Part…

coloppsg2

attachment

ACRCSP Quality Reporting of Colonoscopy Performance Standards Feb 2013

attachment

Quality Reporting of Colonoscopy Performance Standards for the Alberta Colorectal Cancer Screening Program Prepared by Daniel C. Sadowski MD FRCP Quality Lead for the Alberta Colorectal Cancer Screening Program In collaboration with the ACRSCP Quality Working Group Version 8.0, February 5, 2013 Table of Contents Executive Summary .................................................................................................3 I. Introduction:…

coloqual

attachment

ACRCSP Recommendations for Antithrombotic Management Guildelines April 2015

attachment

Alberta Colorectal Cancer Screening Program (ACRCSP) Antithrombotic Management Assessment Tools and Suggested Management for the Patient on Antithrombotics Undergoing a Screening-Related Colonoscopy Version 2.0, Revised April 2015 Revised by Dr. Daniel C. Sadowski MD FRCP(C) and Dr. Clarence K.W. Wong MD FRCP(C) TABLE OF CONTENTS Background................................................................................................................................ 1 Suggested management of…

coloantiman

attachment

ACRCSP Recommendations for Antithrombotic Management Poster April 2015

attachment

Suggested Management of Antithrombotic Agents for a Screening-Related Colonoscopy Antithrombotic Agent Recommended interval between last dose and procedure Recommended interval between procedure and next dose If therapeutic intervention performed* Anticoagulant agent Coumadin® (warfarin) Low molecular weight heparin (LMWH)** Pradaxa® (dabigatran) (Predominantly renal excretion. Assessment of renal function is essential) 5d…

1 46 47 48 49 50 117